WPI-Bio2Q Kickoff Symposium
Human Biology × Microbiome × Quantum Computing
DATE:
ONSITE:ONLINE:CONTACT:

February 3rd, 2023 10:00 – 16:00
Lounge on the first floor,
Center for Integrated Medical Research Center
Keio University Shinanomachi Campus
35 Shinanomachi, Shinjuku-ku, Tokyo, JapanZOOM
Keio University WPI-Bio2Q Office
sc-wpi@adst.keio.ac.jp +81-3-5363-3473 (ex. 64022)

10:00 – 10:10 Opening Remarks /Lounge
Akira Ukawa / Program Director, World Premier International Research Center Initiative; on site
Kenya Honda /Center Director of Bio2Q / Keio University School of Medicine; on site
10:10-1１：4０ / Lounge

chaired by Timur Tuganbaev❶Kenya Honda /Center Director of Bio2Q / Keio University School of Medicine; on site
Toward Development of Defined Microbial Therapeutics❷Jun Huh /Harvard Medical School, US; on line
Neuroimmune Interaction Underlies Both Neurodevelopmental and Immune-Primed Phenotypes❸Yasuyo Minagawa /Keio University Faculty of Letters; on site
Diverse Neurocognitive Development in Infants with and without Elevated Likelihood of ASD
11:40-12:10 / Lounge

chaired by Kenji Tanaka❹Radu Aricescu /MRC Laboratory of Molecular Biology, UK; on site
The Structural Biology of Synaptic Connectivity
12:10-13:00 【Lunch】
13:00-1４:00 / Lounge

chaired by Norio Takata❺George Augustine /Lee Kong Chian School of Medicine /Nanyang Technological University,Singapore; on line
Synapses: The Keys to Understanding Brain Function and Gut-Brain Interactions❻Hideaki Kawaguchi /Keio University Graduate School of Science and Technology; on site
Medical and Biological Applications of Quantum Computing: Current and Future
1４:00-15:00 / Lounge

chaired by Kazuyoshi Ishigaki❼Michisuke Yuzaki /Keio University School of Medicine; on site
Approaching the Gut-Brain Axis from the Synapse❽Makoto Arita /Keio University Faculty of Pharmacy; on site
Cutting-Edge Lipidomics Technology Reveals the Biology of Lipid Diversity and Disease Control
15:00-15:20 【Coffee Break】 / Lounge
15:20-15:50 / Lounge

chaired by Kazuyoshi Ishigaki❾Oltea Sampetrean /Administrative director of Bio2Q /Keio University School of Medicine; on site
Biological and Therapeutic Challenges in Malignant Brain Tumors
15:50 – 16:00 Closing Remarks /Lounge
Oltea Sampetrean /Administrative director of Bio2Q /Keio University School of Medicine; on site

Keio University

WPI-Bio2Q

Kickoff Symposium× Microbiome × Quantum Computing

DateVenue

February 3, 2023 (Fri.)
10:00-16:00 JST(UTC+9)

Hybrid (On-site & Zoom Online) /Free Admission
On-site (invited guests only) : Keio University Shinanomachi Campus
1F Lounge, Center for Integrated Medical Research
35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582 JapanS p e a k e r s(Alphabetical Order) :*Streamed from Onsite Venue (Shinanomachi Campus)

Radu Aricescu

MRC Laboratory of Molecular Biology, UK

Makoto Arita

Keio University Faculty of Pharmacy

George Augustine

Lee Kong Chian School of Medicine/ Nanyang Technological
University, Singapore

Kenya Honda

Center Director of Bio2Q/ Keio University School of MedicineHideaki Kawaguchi

Keio University Graduate School of Science and Technology

Yasuyo Minagawa
Keio University Faculty of Letters

Oltea Sampetrean
Keio University School of Medicine

Michisuke Yuzaki
Keio University School of Medicine

Jun HuhHarvard Medical School, US

The Bio2Q is the first microbiome research center in Japan. We aim tounderstand the interactions between the microbiome and humans at
the molecular level. To understand this complex network, we will use
quantum computing together with bioanalytical methods. In thefuture, we hope to develop new treatments for diseases that are
currently difficult to treat. We want to make our organization
attractive to diverse researchers and competitive on a global level.

Organizer: Keio University Bio2Q Office
Contact: sc-wpi@adst.keio.ac.jp
Website: https://www.bio2q.keio.ac.jp

Registration